FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Teresa Allende

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Cytosol

Concepts & Ideas

Procedures

Radioligand Assay

Co-author Network

Publications

TOP 3
J M Del Casar; A Martín; C García; María D Corte; Ana Alvarez; Sara Junquera; Luis O González; M Bongera; José L García-Muñiz; M Teresa Allende; Francisco J Vizoso
Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.
José M Del Casar; María D Corte; Ana Alvarez; Isabel García; Miguel Bongera; Luis O González; José L García-Muñiz; M Teresa Allende; AURORA ASTUDILLO; Francisco J Vizoso
Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance.
María D Corte; Luis O González; María L Lamelas; Ana Alvarez; Sara Junquera; M Teresa Allende; José L García-Muñiz; Juan Arguelles; Francisco J Vizoso
Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Teresa Allende (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: J M Del Casar; A Martín; C García; María D Corte; Ana Alvarez; Sara Junquera; Luis O González; M Bongera; José L García-Muñiz; M Teresa Allende; Francisco J Vizoso
Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis.
European journal of obstetrics, gynecology, and reproductive biology 2008;141(2):147-52.
2008: José M Del Casar; María D Corte; Ana Alvarez; Isabel García; Miguel Bongera; Luis O González; José L García-Muñiz; M Teresa Allende; AURORA ASTUDILLO; Francisco J Vizoso
Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance.
Journal of cancer research and clinical oncology 2008;134(2):153-61.
2006: María D Corte; Luis O González; María L Lamelas; Ana Alvarez; Sara Junquera; M Teresa Allende; José L García-Muñiz; Juan Arguelles; Francisco J Vizoso
Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer.
Breast cancer research and treatment 2006;97(3):329-37.
2006: María D Corte; Francisco Tamargo; Ana Alvarez; Juan C Rodríguez; Julio Vázquez; Rosario Sánchez; María L Lamelas; Luis O González; M Teresa Allende; José L García-Muñiz; Antonio Fueyo; Francisco J Vizoso
Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance.
Breast cancer research and treatment 2006;96(1):63-72.
2005: Isabel Quintela; María D Corte; M Teresa Allende; J Vazquez; Juan C Rodríguez; Miguel Bongera; María L Lamelas; LO Gonzalez; A Vega; José L García-Muñiz; AURORA ASTUDILLO; Francisco J Vizoso
Expression and prognostic value of EGFR in invasive breast cancer.
Oncology reports 2005;14(6):1655-63.
2005: María D Corte; Juan A Rodil; Julio Vázquez; Lucia García; Juan C Rodríguez; Miguel Bongera; José C Fernández; Luis O González; María L Lamelas; M Teresa Allende; José L García-Muñiz; Antonio Fueyo; Francisco J Vizoso
Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA).
Journal of cancer research and clinical oncology 2005;131(11):701-14.
2005: J Rodríguez; Julio Vázquez; María D Corte; María L Lamelas; Miguel Bongera; María G Corte; Ana Alvarez; M Teresa Allende; L Gonzalez; M Sánchez; Manuel Vijande; J Garcia Muñiz; Francisco J Vizoso
Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer.
The International journal of biological markers 2005;20(2):103-11.
2005: María D Corte; Paula Vérez; Juan C Rodríguez; Antonio Roibás; M Luz Domínguez; María L Lamelas; Julio Vázquez; José L García-Muñiz; M Teresa Allende; Luis O González; Antonio Fueyo; Francisco J Vizoso
Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance.
Breast cancer research and treatment 2005;90(1):33-40.
2004: Francisco J Vizoso; José C Fernández; María D Corte; Miguel Bongera; Richard R R Gava; M Teresa Allende; José L García-Muñiz; Manuel García-Morán
Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer.
Journal of cancer research and clinical oncology 2004;130(11):679-86.
2004: Francisco J Vizoso; María D Corte; Ana Alvarez; Isabel García; José M Del Casar; Miguel Bongera; Luis O González; José L García-Muñiz; M Teresa Allende
Membranous levels of c-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance.
The International journal of biological markers 2004;19(4):268-74.
2003: M Mulero; P Fernández Raigoso; Julio Vázquez; María L Lamelas; D Corte; M Teresa Allende; J C Rodríguez; Francisco J Vizoso
[Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
Revista española de medicina nuclear 2003;22(6):386-94.
2003: Francisco J Vizoso; M C Fagilde; María D Corte; María G Corte; Richard R R Gava; Miguel Bongera; M Teresa Allende; José L García-Muñiz
Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors.
The International journal of biological markers 2003;18(4):301-10.
2003: Isabel García; José M Del Casar; María D Corte; M Teresa Allende; José L García-Muñiz; Francisco J Vizoso
Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.
The International journal of biological markers 2003;18(3):200-6.
2002: L Sanz; Francisco J Vizoso; Paula Vérez; M Teresa Allende; María G Corte; O Abdel-Lah; A Martín; José L García-Muñíz
Prognostic significance of tissue-type plasminogen activator (tPA) content in gastric cancer and surrounding mucosa.
The International journal of biological markers 2002;17(3):169-76.
2002: F Tamargo; Francisco J Vizoso; María L Lamelas; A Rodil; Paula Vérez; Pablo Raigoso; M Mulero; Julio Vázquez; Carmen Roiz; M Teresa Allende
[Analysis of the cytosolic content of the pS2 protein in breast cancer].
Revista española de medicina nuclear 2002;21(1):28-33.
2002: Jesús María Fernández Gómez; Jorge García Rodríguez; Safwan Escaf Barmadah; Pablo Raigoso; Juan Javier Rodríguez Martínez; M Teresa Allende; Javier Casasola Chamorro; Oscar Rodríguez Faba; José Luis Martín Benito; Francisco Javier Regadera Sejas
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Archivos españoles de urología 2002;55(1):41-9.
2001: Isabel García; Francisco J Vizoso; Alejandro Andicoechea; Pablo Raigoso; Paula Vérez; E Alexandre; José L García-Muñiz; M Teresa Allende
Clinical significance of epidermal growth factor receptor content in gastric cancer.
The International journal of biological markers 2001;16(3):183-8.
2001: C Suárez; Francisco J Vizoso; JC Rodríguez; Isabel García; Pablo Raigoso; M Teresa Allende; José L García-Muñíz; Manuel García-Morán
Prognostic significance of cytosolic pS2 protein content in gastric cancer.
The International journal of biological markers 2001;16(1):37-44.
2000: A Llaneza; Francisco J Vizoso; JC Rodríguez; Pablo Raigoso; José L García-Muñiz; M Teresa Allende; Manuel García-Morán
Hyaluronic acid as prognostic marker in resectable colorectal cancer.
The British journal of surgery 2000;87(12):1690-6.
2000: Isabel García; Francisco J Vizoso; Alejandro Andicoechea; P Fernandez; C Suarez; J L García-Muñz; M Teresa Allende
C-erbB-2 oncoprotein content in gastric cancer and in adjacent mucosa.
The International journal of biological markers 2000;15(3):231-4.
2000: M Teresa Allende; Francisco J Vizoso; C Suárez; Isabel García; L Sanz; José L García-Muñiz; Carmen Roiz
TAG-72 in gastric cancer: relationship between preoperative serum levels and tumoral content of the antigen.
The International journal of biological markers 2000;15(2):197-9.
2000: A Llaneza; A Gonzalez; Alejandro Andicoechea; J C Fernandez; M Teresa Allende; José L García-Muñiz; Francisco J Vizoso
CD44s, CD44v5 and CD44v6 protein contents in colorectal cancer and surrounding mucosa.
The International journal of biological markers 2000;15(2):192-4.
2000: Francisco J Vizoso; C Villar; JC Rodríguez; Pablo Raigoso; José L García-Muñiz; M Teresa Allende; M García-Moran
C-erbB-2 oncoprotein content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
International journal of surgical investigation 2000;1(6):483-93.
2000: Pablo Raigoso; A Junco; Alejandro Andicoechea; A Gonzalez; José L García-Muñiz; M Teresa Allende; Manuel García-Morán; Francisco J Vizoso
Tissue-type plasminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance.
The International journal of biological markers 2000;15(1):44-50.
2000: Juan Javier Rodríguez Martínez; Safwan Escaf Barmadah; M Teresa Allende; Pablo Raigoso; José Luis Martín Benito; Francisco Javier Pérez García; Jesús María Fernández Gómez
[Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage].
Archivos españoles de urología 2000;53(1):1-6.
1999: A Junco; J C Rodríguez; M Teresa Allende; José L García-Muñiz; JJ González; Francisco J Vizoso
The pS2 protein in primary colorectal carcinomas and in surrounding mucosa.
The International journal of biological markers 1999;14(3):189-91.
1999: M Teresa Allende; Pablo Raigoso; A Alvarez; Belén Llana; A Sánchez; M I Martínez; M T Miralles; Carmen Roiz
[Valoration of the epidermal growth factor receptor (EGFR) in benign breast disease and its relation with expression in malignant tumors classified by hormonal dependence].
Revista española de medicina nuclear 1999;18(1):32-6.
1998: Alejandro Andicoechea; Francisco J Vizoso; E Alexandre; Juan Carlos Rodriguez; Isabel Quintela; M Teresa Allende; A Ruibal
Carbohydrate antigen 195 (CA 195) in the sera of patients with esophageal, hepatic and biliary tract carcinomas.
The International journal of biological markers 1998;13(2):102-4.